Clinical Trial Update: EGCG Improves Acne by Modulating Molecular Targets [NA]

View source ↗

Summary

Completed clinical trial evaluating epigallocatechin gallate (EGCG) for improving acne by modulating molecular targets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Epigallocatechin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acne Vulgaris | NA | Status: COMPLETED